4//SEC Filing
Opfermann Andreas 4
Accession 0001062993-22-011627
CIK 0001707925other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 3:15 PM ET
Size
19.1 KB
Accession
0001062993-22-011627
Insider Transaction Report
Form 4
LINDE PLCLIN
Opfermann Andreas
Executive VP, Americas
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-05-03−387→ 0 totalExercise: $1.92From: 2021-06-07Exp: 2022-06-07→ Ordinary Shares (387 underlying) - Exercise/Conversion
Ordinary Shares
2022-05-03$1.92/sh+387$743→ 1,857 total - Sale
Ordinary Shares
2022-05-03$311.55/sh−186$57,948→ 1,671 total
Holdings
- 2,145
Restricted Stock Units
Exercise: $0.00→ Ordinary Shares (2,145 underlying) - 19,070
Stock Option (right to buy)
Exercise: $253.68From: 2022-03-08Exp: 2031-03-08→ Ordinary Shares (19,070 underlying) - 3,600
Stock Option (right to buy)
Exercise: $176.63From: 2020-03-20Exp: 2029-03-20→ Ordinary Shares (3,600 underlying) - 1,365
Restricted Stock Units
Exercise: $0.00→ Ordinary Shares (1,365 underlying) - 11,830
Stock Options (right to buy)
Exercise: $270.99From: 2023-03-07Exp: 2032-03-07→ Ordinary Shares (11,830 underlying) - 1,810
Restricted Stock Units
Exercise: $0.00→ Ordinary Shares (1,810 underlying) - 26,090
Stock Option (right to buy)
Exercise: $173.13From: 2021-03-09Exp: 2030-03-09→ Ordinary Shares (26,090 underlying)
Footnotes (9)
- [F1]Ordinary shares sold to pay exercise price and taxes, and the reporting person retained the 201 shares net of the sale of shares.
- [F2]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
- [F3]Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
- [F4]Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
- [F5]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
- [F6]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
- [F7]This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
- [F8]Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
- [F9]This option vests over three years in three consecutive equal annual installments beginning on March 20,2020.
Issuer
LINDE PLC
CIK 0001707925
Entity typeother
Related Parties
1- filerCIK 0001793274
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 3:15 PM ET
- Size
- 19.1 KB